STARmed Biliary RFA Clinical Articles
Endobiliary Radiofrequency Ablation (RFA) is a well-established treatment for several benign, premalignant, and malignant disorders with emerging indications and applications for endoluminal RFA. RFA has produced promising outcomes in patients with a variety of biliary and pancreatic conditions
Percutaneous endobiliary radiofrequency ablation and stent placement for unresectable malignant biliary obstruction: a propensity score matching retrospective study
2025
Efficacy and safety of percutaneous transhepatic biliary radiofrequency ablation in patients with malignant obstructive jaundice
2025
Outcomes of percutaneous endobiliary radiofrequency ablation in managing resistant benign biliary strictures: a retrospective analysis
2024
Percutaneous endobiliary radiofrequency ablation with stent placement in type IV hilar cholangiocarcinoma: a prospective comparison with stent placement alone
2024
Percutaneous endobiliary ablation of malignant biliary strictures with a novel temperature-controlled radiofrequency ablation device
2022
Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial
2022
Efficacy and safety of percutaneous endobilliary radiofrequency ablation with a novel temperature-controlled catheter in malignant biliary strictures
2022
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
2022
Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial
2022